Malignant melanoma: Classification and staging of malignant melanoma

Frontiers of Radiation Therapy and Oncology

Volumn 39, Issue , 2006, Pages 149-158

  Eigentler, Thomas K ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CLASSIFICATION; HUMAN; MELANOMA; PATHOLOGY; PROGNOSIS; REVIEW; SKIN TUMOR;

HUMANS; MELANOMA; NEOPLASM STAGING; PROGNOSIS; SKIN NEOPLASMS;

EID: 33644618944     PISSN: 00719676     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (16)

1. American Cancer Society: How many people get melanoma skin cancer? American Cancer Society. http://www.cancer.org/docroot/CRI/content/ CRI_2_2_1X_How_many_people_get_ melanoma_skin_cancer_50.asp?sitearea. 22-2-2005.
2. Carlson JA, Slominski A, Linette GP, Mysliborski J, Hill J, Mihm MC Jr, et al: Malignant melanoma 2003: Predisposition, diagnosis, prognosis, and staging. Am J Clin Pathol 2003;120(suppl):S101-S127.
3. Ahmed I: Malignant melanoma: Prognostic indicators. Mayo Clin Proc 1997;72:356-361.
4. Krown SE, Chapman PB: Defining adequate surgery for primary melanoma. N Engl J Med 2004;350:823-825.
5. American Cancer Society: Cancer facts & figures. http://www.cancer. org/downloads/STT/CAFF_finalPWSecured.pdf. 2004. Atlanta, American Cancer Society. 29-4-2004.
6. Eigentler TK, Caroli UM, Radny P, Garbe C: Palliative therapy of disseminated malignant melanoma: A systematic review of 41 randomised clinical trials. Lancet Oncology 2003;4:748-759.
7. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635-3648.
8. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al: Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634.
9. Fleming ID, Cooper JS, Henson DE: AJCC Cancer Staging Manual. Philadelphia, Lippincott-Raven, 1997.
10. Leiter U, Büttner P, Eigentler TK, Garbe C: Prognostic factors of thin cutaneous melanoma with 1 mm or less in tumor thickness. An analysis of the German Central Malignant Melanoma Registry of the German Dermatological Society. J Clin Oncol 2004;22:3660-3667.
11. Buzaid AC, Anderson CM: The changing prognosis of melanoma. Curr Oncol Rep 2000;2:322-328.
12. Vollmer R: Malignant melanoma: A multivariate analysis of prognostic factors. Pathol Annu 1989;24:383-407.
13. Eigentler TK, Buettner PG, Leiter U, Garbe C: Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: An analysis of the German Central Malignant Melanoma Registry. J Clin Oncol 2004;22:4376-4383.
14. Hermanek P, Hutter RV, Sobin LH, Wittekind C: International Union Against Cancer. Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673.
15. Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M, et al: Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy. J Clin Oncol 2003;21:520-529.
16. Schlemmer HP, Schäfer J, Pfannenberg C, Radny P, Korchidi S, Müller-Horvat C, et al: Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: Initial experiences. Invest Radiol 2005;40:64-71.